Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Alzamend Neuro Inc.

    NASDAQ: ALZN · Real-Time Price · USD
    2.26
    -0.08 (-3.42%)
    At close: Aug 20, 2025, 3:59 PM
    2.25
    -0.44%
    After-hours: Aug 20, 2025, 07:25 PM EDT

    Alzamend Neuro Income Statement

    Financials in USD. Fiscal year is May - April.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
    Revenue
    		 n/a n/a n/a n/a n/a
    Cost of Revenue
    		 50.74K n/a n/a n/a n/a
    Gross Profit
    		 -50.74K -50.74K -23.07K n/a n/a
    Operating Income
    		 -4.5M -9.94M -14.87M -12.32M -4.95M
    Interest Income
    		 n/a n/a 7.70 46.52 1.71K
    Pretax Income
    		 -4.51M -9.95M -14.88M -12.36M -5.05M
    Net Income
    		 -4.51M -9.95M -14.88M -12.36M -5.05M
    Selling & General & Admin
    		 3.03M 3.48M 7.42M 7.12M 3.64M
    Research & Development
    		 1.41M 6.46M 7.45M 5.2M 1.31M
    Other Expenses
    		 n/a n/a n/a n/a n/a
    Operating Expenses
    		 4.45M 9.94M 14.87M 12.32M 4.95M
    Interest Expense
    		 18.03K 10.1K 7.7K 46.52K 158.8K
    Selling & Marketing Expenses
    		 n/a n/a 742.6K n/a n/a
    Cost & Expenses
    		 4.5M 9.94M 14.87M 12.32M 4.95M
    Income Tax Expense
    		 n/a n/a -145K 42.52K n/a
    Shares Outstanding (Basic)
    		 450.8K 3.38M 3.25M 2.96M 2.42M
    Shares Outstanding (Diluted)
    		 450.8K 3.38M 3.25M 2.97M 2.42M
    EPS (Basic)
    		 -11.32 -14.72 -2.25 -20.92 -0.89
    EPS (Diluted)
    		 -11.32 -14.7 -2.25 -2.1 -0.89
    EBITDA
    		 -4.45M -9.89M -14.85M -12.32M -4.95M
    EBIT
    		 -4.5M -9.94M -14.87M -12.32M -4.89M
    Depreciation & Amortization
    		 50.74K 50.74K 23.07K 3.55K 4.95M

    Add to Watchlist